A phase III trial-in-progress called REPLATINUM that compares RRx-001+a platinum doublet to a platinum doublet in third-line or beyond small cell lung cancer.
Meeting Abstract
Morgensztern, Daniel; Huang, Chao Hui; Rolfo, Christian Diego; Ruckdeschel, John C.; Dragnev, Konstantin H.; Aljumaily, Raid; Hauke, Ralph J.; Mekhail, Tarek; Fidler, Mary J.; Hamm, John Turner; Chiappori, Alberto